A detailed history of Harvest Management LLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Harvest Management LLC holds 10,900 shares of CYTK stock, worth $539,114. This represents 0.29% of its overall portfolio holdings.

Number of Shares
10,900
Previous 14,200 23.24%
Holding current value
$539,114
Previous $769,000 25.23%
% of portfolio
0.29%
Previous 0.59%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$51.22 - $60.16 $169,026 - $198,528
-3,300 Reduced 23.24%
10,900 $575,000
Q2 2024

Aug 14, 2024

BUY
$47.86 - $75.05 $440,312 - $690,460
9,200 Added 184.0%
14,200 $769,000
Q1 2024

May 15, 2024

SELL
$63.75 - $108.06 $637,500 - $1.08 Million
-10,000 Reduced 66.67%
5,000 $350,000
Q4 2023

Feb 14, 2024

BUY
$26.88 - $83.49 $403,200 - $1.25 Million
15,000 New
15,000 $1.25 Million

Others Institutions Holding CYTK

About CYTOKINETICS INC


  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $4.66B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track This Portfolio

Track Harvest Management LLC Portfolio

Follow Harvest Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harvest Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Harvest Management LLC with notifications on news.